ストックスクリーナーアプリを入手
0.581
1.29%
-0.0167
アフターアワーズ：
.58
-0.001
-0.17%
前日終値:
$0.5977
開ける：
$0.609
24時間の取引高:
13,958
Relative Volume:
0.00
時価総額：
$6.22M
収益：
-
当期純損益:
-
株価収益率:
-1.5741
EPS:
-0.3691
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-11.94%
1か月 パフォーマンス:
+18.71%
6か月 パフォーマンス:
-30.99%
1年 パフォーマンス:
-64.67%
1日の値動き範囲:
$0.5705
$0.609
1週間の範囲:
$0.5559
$0.708
52週間の値動き範囲:
$0.387
$2.02
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
0.581 | 6.40M | 0 | 0 | 0 | -0.3691 |
TAK
Takeda Pharmaceutical Co Adr
|
16.96 | 53.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.84 | 42.80B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.65 | 41.09B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.29 | 31.62B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
563.70 | 23.23B | 3.17B | 1.29B | 1.01B | 27.09 |
Gelteq Ltd (GELS) 最新ニュース
Gelteq (GELS) wins shareholder approval and closes $2.5M second tranche note - Stock Titan
GELSGelteq Ltd Short Interest - Finviz
Gelteq (GELS) faces $5.3M working capital deficit and rising debt - Stock Titan
Gelteq Company Profile & Introduction - Moomoo
Gelteq Ltd (GELS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Gelteq Ltd (GELS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Gelteq Ltd (GELS) Institutional Confidence - TradingKey
Gelteq Ltd (GELS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Gelteq Ltd (GELS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Gelteq advances clinical programs across pharmaceutical and veterinary applications By Investing.com - Investing.com India
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs - The Manila Times
Gelteq lines up first human trial, vet study and $3.5M financing - Stock Titan
Gelteq Ltd (GELS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Gelteq Ltd (GELS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Gelteq Ltd (GELS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GELS Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
$Gelteq (GELS.US)$ thank you - Moomoo
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - The Manila Times
What's Going On With Gelteq Stock Friday?Gelteq (NASDAQ:GELS) - Benzinga
Dogs accept gels that hide bitter medicine, Gelteq trials show - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
$Gelteq (GELS.US)$ 👍 sold all already. thank you![Drool][Cool Guy][Rich][Peace][Blessing] - Moomoo
Gelteq establishes Centre of Excellence in China to accelerate product development - BioSpectrum Asia
Gelteq establishes center of excellence in China’s Guangdong By Investing.com - Investing.com South Africa
Gelteq establishes center of excellence in China’s Guangdong - Investing.com
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion - The Manila Times
Gelteq sets up Guangdong hub as China biotech deals near $60B - Stock Titan
Gelteq Limited announced that it expects to receive $3.5 million in funding - marketscreener.com
Gelteq (GELS) calls Special Meeting on convertible note share issuance and 9.99% cap - Stock Titan
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities - MSN
Gelteq secures up to $3.5 million in convertible debt financing By Investing.com - Investing.com India
Gelteq secures up to $3.5 million in convertible debt financing - Investing.com
Gelteq (NASDAQ: GELS) inks up to $3.5M structured convertible note deal - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Gelteq begins clinical trial for veterinary antiparasitic drug - Investing.com
Gelteq begins clinical trial for veterinary antiparasitic drug By Investing.com - Investing.com South Africa
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - The Manila Times
Inside Gelteq’s first vet drug trial in a $78B animal health market - Stock Titan
Gelteq secures up to $3.5M debt financing to support commercialization - MSN
Sommer Ray’s Imaraïs taps Healthy Extracts to make 4M beauty gummies - Stock Titan
TradingKey - TradingKey
Gelteq announces USD $3.5 million strategic debt financing to accelerate commercialization and support revenue growth - marketscreener.com
Gelteq Secures USD $3.5 Million in Debt Financing on May 12, 2026 - geneonline.com
Gelteq secures up to $3.5M debt financing for trials - Investing.com
Gelteq secures up to $3.5M debt financing for trials By Investing.com - Investing.com India
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - marketscreener.com
Gelteq lands $3.5M to speed its pharmaceutical and nutraceutical gels - Stock Titan
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - MSN
What makes Gelteq Limited (GELS) a compelling holding for the long term (Hovering) 2026-05-08Trending Entry Points - Newser
Gelteq Ltd (GELS) 財務データ
収益
当期純利益
現金流量
EPS
0.17%
1.98%
大文字化:
|
ボリューム (24 時間):